CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 242 filers reported holding CYTOKINETICS INC in Q1 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,051,295 | -58.7% | 58,292 | -46.2% | 0.00% | -66.7% |
| Q4 2022 | $4,962,810 | +54.4% | 108,311 | +63.2% | 0.01% | +50.0% |
| Q3 2022 | $3,215,000 | +134.7% | 66,364 | +90.3% | 0.00% | +100.0% |
| Q2 2022 | $1,370,000 | -44.4% | 34,879 | -47.9% | 0.00% | -33.3% |
| Q1 2022 | $2,466,000 | -64.9% | 67,002 | -56.5% | 0.00% | -57.1% |
| Q4 2021 | $7,023,000 | +367.9% | 154,079 | +103.1% | 0.01% | +250.0% |
| Q2 2021 | $1,501,000 | +31.0% | 75,858 | +53.9% | 0.00% | +100.0% |
| Q1 2021 | $1,146,000 | +42.5% | 49,288 | +27.3% | 0.00% | 0.0% |
| Q4 2020 | $804,000 | – | 38,705 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |